Liposomal paclitaxel induces apoptosis, cell death, inhibition of migration capacity and antitumoral activity in ovarian cancer

Autor: Raquel Santos Faria, Luiza Ianny de Lima, Raphael Severino Bonadio, João Paulo Figueiró Longo, Marjorie Coimbra Roque, João Nunes de Matos Neto, Sergio Enrique Moya, Mônica Cristina de Oliveira, Ricardo Bentes Azevedo

Publikováno v: Biomedicine & Pharmacotherapy, Vol 142, Iss , Pp 112000- (2021)

The main goal of this study is to evaluate the efficacy of the paclitaxel (PTX) drug formulated with a liposomal nanosystem (L-PTX) in a peritoneal carcinomatosis derived from ovarian cancer. In vitro cell viability studies with the human ovarian can

Externí odkaz: https://doaj.org/article/24cfd717c26248fb88514df753567e03

Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19

Autor: Cristiane Decat Bergerot, Jasnoor Malhotra, Paulo Bergerot, Errol J Philip, Daniela V Castro, JoAnn Hsu, Augusto Cesar de Andrade Mota, Andressa Cardoso de Azeredo, João Nunes de Matos Neto, Thomas Hutson, Viktor Grünwald, Axel Bex, Sarah P Psutka, Brian Rini, Elizabeth R Plimack, Viraj Master, Laurence Albiges, Toni K Choueiri, Sumanta Pal, Thomas Powles

BackgroundThere is a lack of consensus regarding the optimal method of assessing health-related quality of life (HR-QOL) among patients with metastatic renal cell carcinoma (mRCC). This study explored the perceived relevance of items that make up the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f3ac99b23f9110d91401e62ce1afde1
https://www.ncbi.nlm.nih.gov/pubmed/36917626

Liposomal paclitaxel induces apoptosis, cell death, inhibition of migration capacity and antitumoral activity in ovarian cancer

Autor: Raphael Severino Bonadio, Mônica Cristina de Oliveira, Marjorie Coimbra Roque, João Paulo Figueiró Longo, Raquel Santos Faria, Luiza Ianny de Lima, Sergio Moya, Ricardo Bentes Azevedo, João Nunes de Matos Neto

Publikováno v: Repositório Institucional da UnB
Universidade de Brasília (UnB)
instacron:UNB
Biomedicine & Pharmacotherapy, Vol 142, Iss, Pp 112000-(2021)

The main goal of this study is to evaluate the efficacy of the paclitaxel (PTX) drug formulated with a liposomal nanosystem ( L -PTX) in a peritoneal carcinomatosis derived from ovarian cancer. In vitro cell viability studies with the human ovarian c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff978dceb3fbf2feb1860787a5093359
https://doi.org/10.1016/j.biopha.2021.112000

Development and implementation of a comprehensive psychosocial screening program in a Brazilian cancer center

Autor: Alexandre Nonino, Tammy A. Schuler, Cristiane Decat Bergerot, João Nunes de Matos Neto, Tereza Cristina Cavalcanti Ferreira de Araujo, Errol J. Philip, Jorge Vaz Pinto Neto, Matthew Loscalzo, Marco Murilo Buso, Karen Clark

Publikováno v: Psycho-Oncology. 25:1343-1349

Objective International guidelines recommend routine screening for distress as part of care practices. Accordingly, a Brazilian cancer center developed and implemented a distress screening program (DS) in 2007, which was enhanced in 2009 through the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7c6f510bc5d6413bc2b32d1d27857025
https://doi.org/10.1002/pon.4275

A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients

Autor: Sabina Bandeira Aleixo, Roberto Odebrecht Rocha, André Mattar, Renato Peixoto Cramer-Junior, Sylvie van-Eyll-Rocha, Jose Luiz Pedrini, João Nunes de Matos-Neto, Roberto Hegg

Publikováno v: Clinics; v. 71 n. 10 (2016); 586-592
Clinics; Vol. 71 Núm. 10 (2016); 586-592
Clinics; Vol. 71 No. 10 (2016); 586-592
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics, Volume: 71, Issue: 10, Pages: 586-592, Published: OCT 2016
Clinics, Vol 71, Iss 10, Pp 586-592

OBJECTIVES: To compare the efficacy and safety of two filgrastim formulations for controlling chemotherapy-induced neutropenia and to evaluate the non-inferiority of the test drug relative to the originator. METHODS: This phase III non-inferiority st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58cbaf535d37ba3e0bfd8f45c21b067c
https://www.revistas.usp.br/clinics/article/view/122233